TVTX NASDAQ
Travere Therapeutics, Inc.
1W: +1.4%
1M: +11.6%
3M: +47.2%
YTD: +13.2%
1Y: +154.8%
3Y: +171.5%
5Y: +144.9%
$44.43
-0.31 (-0.69%)
Weekly Expected Move ±6.1%
$37
$40
$43
$45
$48
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026327
Institutions Holding
+9 vs prior
65.0%
Ownership
-28.95%
46
New
79
Increased
170
Reduced
93
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-06 | Cline Christopher R. | officer: chief financial officer | S-Sale | 310 | $43.95 | $14K | Filing |
| 2026-05-06 | Dube Eric M | officer: chief executive officer | S-Sale | 22,500 | $43.95 | $989K | Filing |
| 2026-05-06 | Inrig Jula | officer: chief medical officer | S-Sale | 311 | $43.95 | $14K | Filing |
| 2026-05-06 | REED ELIZABETH E | officer: chief legal officer and gc | S-Sale | 2,076 | $43.95 | $91K | Filing |
| 2026-05-06 | ROTE WILLIAM E. | officer: chief research officer | S-Sale | 2,763 | $43.95 | $121K | Filing |
| 2026-05-05 | Baynes Roy D. | director | S-Sale | 4,500 | $46.65 | $210K | Filing |
| 2026-05-05 | Cline Christopher R. | officer: chief financial officer | S-Sale | 2,181 | $46.65 | $102K | Filing |
| 2026-05-05 | Heerma Peter | officer: chief commercial officer | S-Sale | 2,174 | $46.65 | $101K | Filing |
| 2026-05-05 | Inrig Jula | officer: chief medical officer | S-Sale | 2,174 | $46.65 | $101K | Filing |
| 2026-05-05 | REED ELIZABETH E | officer: chief legal officer and gc | S-Sale | 2,174 | $46.65 | $101K | Filing |
| 2026-05-04 | Meckler Jeffrey A | director | S-Sale | 8,000 | $45.00 | $360K | Filing |
| 2026-05-04 | REED ELIZABETH E | officer: chief legal officer and gc | S-Sale | 20,000 | $45.00 | $900K | Filing |
| 2026-05-04 | Inrig Jula | officer: chief medical officer | S-Sale | 20,000 | $45.00 | $900K | Filing |
| 2026-05-01 | Baynes Roy D. | director | S-Sale | 9,750 | $44.22 | $431K | Filing |
| 2026-04-22 | ROTE WILLIAM E. | officer: chief research officer | S-Sale | 9,100 | $39.09 | $356K | Filing |
| 2026-04-15 | Dube Eric M | officer: chief executive officer | S-Sale | 20 | $42.66 | $853 | Filing |
| 2026-04-15 | Inrig Jula | officer: chief medical officer | S-Sale | 1,018 | $42.61 | $43K | Filing |
| 2026-04-15 | Cline Christopher R. | officer: chief financial officer | S-Sale | 1,014 | $42.61 | $43K | Filing |
| 2026-04-15 | REED ELIZABETH E | officer: chief legal officer and gc | S-Sale | 1,559 | $42.53 | $66K | Filing |
| 2026-04-15 | REED ELIZABETH E | officer: chief legal officer and gc | S-Sale | 5,226 | $41.62 | $218K | Filing |
| 2026-04-15 | Dube Eric M | officer: chief executive officer | S-Sale | 7,165 | $41.75 | $299K | Filing |
| 2026-04-15 | Dube Eric M | officer: chief executive officer | S-Sale | 56,815 | $41.01 | $2.3M | Filing |
| 2026-04-14 | Inrig Jula | officer: chief medical officer | S-Sale | 7,215 | $41.93 | $303K | Filing |
| 2026-04-14 | Cline Christopher R. | officer: chief financial officer | S-Sale | 9 | $41.07 | $370 | Filing |
| 2026-04-14 | REED ELIZABETH E | officer: chief legal officer and gc | S-Sale | 37,500 | $41.07 | $1.5M | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 11,419,586 | $339M | +908,420 | 2026-03-31 | Filing |
| FMR LLC | 10,967,967 | $326M | +1,350,104 | 2026-03-31 | Filing |
| BlackRock, Inc. | 7,792,033 | $232M | -77,319 | 2026-03-31 | Filing |
| STATE STREET CORP | 4,959,988 | $147M | +203,322 | 2026-03-31 | Filing |
| ARMISTICE CAPITAL, LLC | 4,897,417 | $146M | +1,133,526 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,045,812 | $120M | +4,045,812 | 2026-03-31 | Filing |
| NOMURA ASSET MANAGEMENT INTERNATIONAL IN | 3,270,513 | $97M | -503,051 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2,369,559 | $70M | +226,064 | 2026-03-31 | Filing |
| RENAISSANCE TECHNOLOGIES LLC | 1,966,779 | $58M | -280,000 | 2026-03-31 | Filing |
| Stephens Investment Management Group LLC | 1,798,466 | $53M | +76,843 | 2026-03-31 | Filing |
| GOLDMAN SACHS GROUP INC | 1,719,721 | $51M | -148,491 | 2026-03-31 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,709,139 | $51M | +1,709,139 | 2026-03-31 | Filing |
| Kynam Capital Management, LP | 1,569,018 | $47M | +1,051,134 | 2026-03-31 | Filing |
| EMERALD ADVISERS, LLC | 1,557,196 | $46M | -36,988 | 2026-03-31 | Filing |
| Rock Springs Capital Management LP | 1,477,954 | $44M | -732,368 | 2026-03-31 | Filing |
| BANK OF AMERICA CORP /DE | 1,345,111 | $40M | -505,244 | 2026-03-31 | Filing |
| Driehaus Capital Management LLC | 1,282,518 | $38M | +381,114 | 2026-03-31 | Filing |
| WELLINGTON MANAGEMENT GROUP LLP | 1,022,272 | $30M | +223,288 | 2026-03-31 | Filing |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 977,000 | $29M | -1,950,000 | 2026-03-31 | Filing |
| EMERALD MUTUAL FUND ADVISERS TRUST | 945,033 | $28M | -3,426 | 2026-03-31 | Filing |